The Next Leap

Login

Subscribe

Brandon Capital collects A$439 million for sixth fund

•

•

Thierry Heles
Brandon Capital

Brandon Capital, an Australian venture capital firm focused on life sciences, has raised A$439 million1 for its sixth fund, closing the vehicle considerably above its target size of A$350 million.

Limited partners in the Brandon BioCatalyst Fund Six include pension funds HESTA and Hostplus.

Keep reading with a free account. Sign up today.
Already a subscriber? Log in.

Found this useful? Share it with colleagues now.

About the author

a headshot of the author
Thierry Heles is the founder and editor of The Next Leap. He has been writing about innovation ecosystems for over 12 years. His research has featured in the UK Spinout Review and University-Investor Review, the Financial Times, and the Wall Street Journal, among others.

Explore these topics

Sector(s):
Subject(s):
Region(s): , ,

LATEST News

The Next Leap